Crossmark

Ipilimumab treatment associated with myasthenic crises and unfavorable disease course

Crossref DOI link: https://doi.org/10.1007/s10072-018-3471-6

Published Online: 2018-06-13

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Derle, Eda https://orcid.org/0000-0003-2122-1016
Benli, Sibel
License Information

Text and Data Mining valid from 2018-06-13
More Information

Article History

Received: 17 March 2018

Accepted: 6 June 2018

First Online: 13 June 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.